Bristol-Myers Squibb Stock To Go Ex-dividend Tomorrow (BMY)

NEW YORK ( TheStreet) -- The ex-dividend date for Bristol-Myers Squibb Company (NYSE: BMY) is tomorrow, July 2, 2013. Owners of shares as of market close today will be eligible for a dividend of 35 cents per share. At a price of $44.96 as of 9:30 a.m. ET, the dividend yield is 3%.

The average volume for Bristol-Myers Squibb has been 10.8 million shares per day over the past 30 days. Bristol-Myers Squibb has a market cap of $76.05 billion and is part of the health care sector and drugs industry. Shares are up 37.1% year to date as of the close of trading on Friday.

Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. The company has a P/E ratio of 52, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Bristol-Myers Squibb as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Bristol-Myers Squibb Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact